Gastrin-releasing peptide
Gastrin-releasing peptide (GRP) is a neuropeptide that plays a crucial role in a variety of physiological and pathological processes. It is a 27-amino acid peptide that is primarily produced in the gastrointestinal tract and the central nervous system. GRP is known to stimulate the release of gastrin, a hormone that promotes the secretion of gastric acid in the stomach.
Function
Gastrin-releasing peptide functions as a neurotransmitter and a growth factor. It is involved in numerous physiological processes, including the regulation of gastric acid secretion, smooth muscle contraction, and cell proliferation. In the central nervous system, GRP acts as a neurotransmitter involved in pain transmission, thermoregulation, and circadian rhythms.
Structure
The structure of GRP is characterized by a 27-amino acid peptide chain. The peptide chain is synthesized as a larger precursor molecule, which is then cleaved to produce the active form of GRP. The active form of GRP is highly conserved across different species, indicating its important role in physiological processes.
Clinical significance
Abnormal levels of GRP have been associated with various diseases. Elevated levels of GRP have been found in certain types of cancer, including lung cancer, breast cancer, and prostate cancer. In these cancers, GRP acts as a growth factor, promoting the proliferation of cancer cells. In addition, GRP has been implicated in inflammatory bowel disease, where it is thought to contribute to inflammation and tissue damage.
Research
Research on GRP has focused on its role in disease and potential as a therapeutic target. Studies have investigated the use of GRP antagonists in the treatment of cancer and inflammatory diseases. In addition, research has explored the role of GRP in the central nervous system, with a focus on its potential involvement in neurological and psychiatric disorders.
See also
This peptide related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
